Clinical Trial Update: GEM-CLARIDEX: Ld vs BiRd [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing LD vs BiRD regimens in multiple myeloma; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• GEM-CLARIDEX

Snippet

Sponsor: PETHEMA Foundation | Conditions: Multiple Myeloma | Phase 3 | Status: UNKNOWN